Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Hormonal therapies are safe and effective for treating adult women's acne.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

DA liposomes with chloramphenicol effectively target hair follicles and combat MRSA with minimal skin toxicity.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Nanoemulsions improve stability and delivery of active ingredients in cosmetics for skin and hair care.